Back
RxSight Stock Price Chart
Sponsored
RXST
Sponsored
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30
RXST
RxSight
Last Price:
52.98
Seasonality Move:
-0.72%
7 Day Trial
ALL ACCESS PASS
$
7
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RXST is experiencing selling pressure, which indicates risk of future bearish movement.
RxSight Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 54.55 | Sell |
20-day SMA: | 54.6 | Sell |
50-day SMA: | 50.8 | Buy |
200-day SMA: | 51.31 | Buy |
8-day EMA: | 54.14 | Sell |
20-day EMA: | 53.87 | Sell |
50-day EMA: | 53.08 | Sell |
200-day EMA: | 48.85 | Buy |
RxSight Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.59 | Buy |
Relative Strength Index (14 RSI): | 47.7 | Sell |
Chaikin Money Flow: | -722739 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (53.18 - 55.58) | Sell |
Bollinger Bands (100): | (49.39 - 59.95) | Sell |
RxSight Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for RxSight Stock
Is RxSight Stock a Buy?
- RxSight share price is 52.98 while RXST 8-day simple moving average is 54.55, which is a Sell signal.
- The stock price of RXST is 52.98 while RxSight 20-day SMA is 54.60, which makes it a Sell.
- RxSight 50-day simple moving average is 50.80 while RXST share price is 52.98, making it a Buy technically.
- RXST stock price is 52.98 and RxSight 200-day simple moving average is 51.31, creating a Buy signal.
RXST Technical Analysis vs Fundamental Analysis
RxSight Stock Info
Market Cap:
2.1B
Price in USD:
52.98
Share Volume:
1.36M
RxSight 52-Week Range
52-Week High:
66.54
52-Week Low:
20.66
Sell
30
RxSight (RXST)
is a Sell
RxSight Share Price Forecast
-
What is the RxSight stock price today?
The RxSight stock price is 52.98 USD today. -
Will RXST stock go up or go down?
RxSight> share price is forecast to RISE/FALL based on technical indicators -
Is RxSight overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, RxSight is overvalued.
Is RxSight Stock a Buy?
- RxSight share price is 52.98 while RXST 8-day exponential moving average is 54.14, which is a Sell signal.
- The stock price of RXST is 52.98 while RxSight 20-day EMA is 53.87, which makes it a Sell.
- RxSight 50-day exponential moving average is 53.08 while RXST share price is 52.98, making it a Sell technically.
- RXST stock price is 52.98 and RxSight 200-day simple moving average is 48.85, creating a Buy signal.
Fundamental Analysis of RxSight
Is RxSight a good investment?
- Analysts estimate an earnings increase this quarter of $0.28 per share, an increase next quarter of $0.07 per share, an increase this year of $0.85 per share, and an increase next year of $0.38 per share.
Technical Analysis of RxSight
Should I short RxSight stock?
- RXST Moving Average Covergence Divergence (MACD) indicator is 0.59, suggesting RxSight is a Buy
- RxSight Relative Strength Index (RSI) is 47.7, which suggest RxSight is oversold
- The Bollinger Bands (25) for RxSight is (53.18 - 55.58), which suggest RxSight is a Sell
- The Bollinger Bands (100) for RxSight is (49.39 - 59.95), which suggest RxSight is a Sell
* RxSight stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.